This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NxStage Enhances Patient Awareness Efforts With Launch Of Online Nephrologist Directory To Help Patients Connect With Local System One Prescribers

Stocks in this article: NXTM

LAWRENCE, Mass., Nov. 22, 2011 /PRNewswire/ -- Taking control of your dialysis and finding the information you need about home hemodialysis with the NxStage ® System One just got easier for end stage renal disease (ESRD) patients with the launch of the NxStage Find a Doctor directory.  The on-line directory created by NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, makes it easier for patients to identify a nearby nephrologist with experience caring for home hemodialysis patients using the NxStage System One.  The Find a Doctor directory can be found under the " Home Hemodialysis" tab of NxStage's website.

(Logo: )

Today, the large majority of dialysis patients in the US receive conventional dialysis, which consists of treatment on a Monday/Wednesday/Friday or Tuesday/Thursday/Saturday schedule. This conventional in-center schedule leaves a 2-day gap between the last treatment of the preceding week and the first treatment of the following week, during which time toxins and fluids build up and may stress the heart and body.  Recent publications have shown this long gap between treatments is associated with increased patient hospitalization and mortality.

"With such an extensive pool of published data showing that, when compared with conventional thrice-weekly treatments, daily home hemodialysis can lead to improved health, quality of life and survival outcomes, the Find a Doctor Directory is an especially timely resource to encourage dialogue between patients and physicians who are knowledgeable about this treatment, empowering patients to explore all options for their kidney care," said Robert S. Lockridge, Jr., M.D., medical director of the UVA Home Dialysis program. "Dialysis patients should be informed of all treatment options and have access to the treatment that is right for them, including frequent home hemodialysis."

"Many patients and their families have told us that simplifying access to home hemodialysis would be very beneficial," said Jeffrey H. Burbank, Chief Executive Officer, NxStage Medical Inc. "As a patient focused organization, we believe that our new 'Find a Doctor' directory is a convenient tool to help interested patients identify a local nephrologist and pursue more frequent home hemodialysis.  We thank the many nephrologists that have chosen to collaborate with us in this important effort, and we look to continue to expand this in the future."

To search for a nephrologist, users provide their zip code to access a list of doctors within a designated radius, including contact information. With this information, users can reach out directly to the nephrologist's practice to learn more about more frequent home hemodialysis with the System One.  In addition to the Find a Doctor directory, users can also search the Find a Dialysis Center directory to locate a dialysis center offering training for the NxStage System One.


The Find a Doctor and Find a Dialysis Center directories are not intended as tools for verifying the credentials, qualifications, or abilities of any physician or center contained therein. The use of either directory by any entity or individual to verify the credentials of listed physicians or center is prohibited. Inclusion in either directory does not imply recommendation or endorsement by NxStage nor does omission in either directory imply NxStage disapproval.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs